4.6 Article

Ileal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpgi.00525.2009

Keywords

ileal transposition; obesity; diabetes; incretin; GLP-1

Funding

  1. National Institute of Health [GM-55639, GM-38032, DK-062880]
  2. Pennsylvania Department of Health
  3. Penn State Institute for Diabetes and Obesity

Ask authors/readers for more resources

Culnan DM, Albaugh V, Sun M, Lynch CJ, Lang CH, Cooney RN. Ileal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat. Am J Physiol Gastrointest Liver Physiol 299: G751-G760, 2010. First published July 15, 2010; doi: 10.1152/ajpgi.00525.2009.-The hindgut hypothesis posits improvements in Type 2 diabetes after gastric bypass surgery are due to enhanced delivery of undigested nutrients to the ileum, which increase incretin production and insulin sensitivity. The present study investigates the effect of ileal interposition (IT), surgically relocating a segment of distal ileum to the proximal jejunum, on glucose tolerance, insulin sensitivity, and glucose transport in the obese Zucker rat. Two groups of obese Zucker rats were studied: IT and sham surgery ad libitum fed (controls). Changes in food intake, body weight and composition, glucose tolerance, insulin sensitivity and tissue glucose uptake, and insulin signaling as well as plasma concentrations of glucagon-like peptide-1 and glucose-dependent insulinotropic peptide were measured. The IT procedure did not significantly alter food intake, body weight, or composition. Obese Zucker rats demonstrated improved glucose tolerance 3 wk after IT compared with the control group (P < 0.05). Euglycemic, hyperinsulinemic clamp and 1-[C-14]-2-deoxyglucose tracer studies indicate that IT improves whole body glucose disposal, insulin-stimulated glucose uptake, and the ratio of phospho-to total Akt (P < 0.01 vs. control) in striated muscle. After oral glucose, the plasma concentration of glucagon-like peptide-1 was increased, whereas GIP was decreased following IT. Enhanced nutrient delivery to the ileum after IT improves glucose tolerance, insulin sensitivity and muscle glucose uptake without altering food intake, body weight, or composition. These findings support the concept that anatomic and endocrine alterations in gut function play a role in the improvements in glucose homeostasis after the IT procedure.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Cardiovascular Risk Reduction Following Metabolic and Bariatric Surgery

Vance L. Albaugh, Tammy L. Kindel, Steven E. Nissen, Ali Aminian

Summary: Cardiovascular disease remains a significant burden globally and metabolic surgery may reduce mortality in obese patients.

SURGICAL CLINICS OF NORTH AMERICA (2021)

Letter Surgery

Diabetes control before metabolic and bariatric surgery

Vance L. Albaugh, Ali Aminian

SURGERY FOR OBESITY AND RELATED DISEASES (2022)

Review Endocrinology & Metabolism

Regulation of body weight: Lessons learned from bariatric surgery

Vance L. Albaugh, Yanlin He, Heike Munzberg, Christopher D. Morrison, Sangho Yu, Hans-Rudolf Berthoud

Summary: Bariatric surgery is an effective treatment for obesity and metabolic disease, but limited in availability. Research is needed to understand the molecular mechanisms involved and develop targeted behavioral or pharmacological treatments. Gut-brain communication and its effects on food intake control and energy balance regulation are complex and redundant. Advanced techniques and animal models are necessary for further investigation.

MOLECULAR METABOLISM (2023)

Meeting Abstract Endocrinology & Metabolism

Weight-Independent Effects of Roux-en-Y Gastric Bypass Surgery on Remission of Nonalcoholic Fatty Liver Disease in Mice

Christopher L. Axelrod, Ingeborg M. Langohr, Wagner S. Dantas, R. Leigh Townsend, Vance L. Albaugh, John P. Kirwan, Hans-Rudolf Berthoud

DIABETES (2022)

Article Surgery

Effect of high-risk factors on postoperative major adverse cardiovascular and cerebrovascular events trends following bariatric surgery in the United States from 2012 to 2019

Linda Adepoju, Denise Danos, Christian Green, Michael W. Cook, Philip R. Schauer, Vance L. Albaugh

Summary: This study examined trends in postoperative major adverse cardiovascular and cerebrovascular events (MACE) after bariatric surgery from 2012 to 2019 using a national inpatient sample database. The study found that the risk of MACE was lowest for laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB), while open sleeve gastrectomy (SG) and open Roux-en-Y gastric bypass (RYGB) had higher risks. MACE incidence increased over time for SG and RYGB but remained relatively stable for LSG and LRYGB.

SURGERY FOR OBESITY AND RELATED DISEASES (2023)

Review Surgery

The role of bariatric and metabolic surgery in the development, diagnosis, and treatment of endometrial cancer

Robert C. Ross, Yetunde M. Akinde, Philip R. Schauer, Carel W. le Roux, Donal Brennan, Amelia M. Jernigan, Marco Bueter, Vance L. Albaugh

Summary: The obesity pandemic contributes to various diseases including diabetes, cardiovascular disease, and cancer. Metabolic and bariatric surgery is considered the most effective treatment for obesity and may also have a protective benefit in terms of cancer incidence, particularly for endometrial cancer. Gynecologic oncologist visits provide an opportunity to identify patients who may benefit the most from metabolic surgery as a potential treatment for endometrial cancer.

FRONTIERS IN SURGERY (2022)

Article Endocrinology & Metabolism

Combination anti-obesity medications to effectively treat bariatric surgery weight regain at an academic obesity center

Gunther Wong, Erica M. Garner, Sahar Takkouche, Matthew D. Spann, Wayne J. English, Vance L. Albaugh, Gitanjali Srivastava

Summary: Combination anti-obesity medications may be needed to achieve optimal weight loss results to treat post-operative weight regain.

OBESITY SCIENCE & PRACTICE (2023)

Article Endocrinology & Metabolism

Physiology Reconfigured: How Does Bariatric Surgery Lead to Diabetes Remission?

Vance L. Albaugh, Christopher Axelrod, Kathryn P. Belmont, John P. Kirwan

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2023)

Editorial Material Surgery

Comment on: Resting-state network functional connectivity before and after bariatric surgery

Vance L. Albaugh

SURGERY FOR OBESITY AND RELATED DISEASES (2023)

Editorial Material Nutrition & Dietetics

A Concept for Comprehensive Food is Medicine Networks or Centers of Excellence

Christopher J. Lynch

AMERICAN JOURNAL OF CLINICAL NUTRITION (2023)

Article Surgery

The Vagus Nerve Mediates Gut-Brain Response to Duodenal Nutrient Administration

Robert C. Ross, Yanlin He, R. Leigh Townsend, Philip R. Schauer, Hans-Rudolph Berthoud, Christopher D. Morrison, Vance L. Albaugh

Summary: This study investigated the effects of bariatric surgery on obesity using a mouse model, focusing on the neuro-hormonal mechanisms. The results showed that nutrient signals in the duodenum significantly increased after bariatric surgery. This study suggests that bariatric surgery may alleviate obesity by altering cellular signaling mechanisms in the duodenum.

AMERICAN SURGEON (2023)

Article Endocrinology & Metabolism

Weight-independent effects of Roux-en-Y gastric bypass surgery on remission of nonalcoholic fatty liver disease in mice

Christopher L. Axelrod, Ingeborg Langohr, Wagner S. Dantas, Elizabeth C. Heintz, Bolormaa Vandanmagsar, Shengping Yang, Elizabeth R. M. Zunica, R. Leigh Townsend, Vance L. Albaugh, Hans-Rudolf Berthoud, John P. Kirwan

Summary: Obesity is a driver of non-alcoholic fatty liver disease, and interventions that decrease body weight, such as bariatric surgery and/or calorie restriction, may serve as effective therapies. This study compared the effects of Roux-en-Y gastric bypass surgery and calorie restriction on hepatic function in mice with obesity and NAFLD. The results showed that gastric bypass surgery reduced hepatic lipid content and adiposity while increasing energy expenditure and lean body mass. Gastric bypass surgery also activated enterohepatic signaling and genes regulating hepatic lipid homeostasis.

OBESITY (2023)

Review Surgery

Endoscopic sleeve gastroplasty and its role in the treatment of obesity: a systematic review

Salvatore Docimo Jr, Laura Aylward, Vance L. Albaugh, Cheguevara Afaneh, Sofiane El Djouzi, Mohamed Ali, Maria S. Altieri, Jonathan Carter

SURGERY FOR OBESITY AND RELATED DISEASES (2023)

Article Surgery

Bariatric surgery alters mitochondrial function in gut mucosa

Robert C. Ross, Elizabeth C. Heintz, Elizabeth R. M. Zunica, R. Leigh Townsend, Amanda E. Spence, Philip R. Schauer, John P. Kirwan, Christopher L. Axelrod, Vance L. Albaugh

Summary: This study investigated the effects of MBS surgery on intestinal mitochondrial function in mice. The results showed that ileal interposition decreased mitochondrial volume in the proximal intestinal mucosa of mice, while respiration remained unchanged. Further studies are needed to understand the underlying causes of these mitochondrial changes.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2023)

No Data Available